{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:27:22Z","timestamp":1793953642453,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neuroimage.2026.121953","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:16:24Z","timestamp":1777011384000},"page":"121953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Diagnostic utility of quantitative susceptibility mapping in Parkinson's disease and atypical parkinsonism: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"333","author":[{"given":"Mohammadreza","family":"Tahamtan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Kolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Vahidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahla","family":"Radmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavous","family":"Firouznia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Yousem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuroimage.2026.121953_bib0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/jon.13222","article-title":"Combined MR quantitative susceptibility mapping and multi-shell diffusion in Parkinson's disease","volume":"34","author":"Andersson Forsman","year":"2024","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.neuroimage.2026.121953_bib0030","article-title":"Quantitative susceptibility mapping reveals differences between subtypes of lewy body dementia","author":"Bhome","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.neuroimage.2026.121953_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.107076","article-title":"Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease","volume":"215","author":"Chen","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroimage.2026.121953_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.102103","article-title":"Imaging the nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: an application to Parkinson's disease","volume":"25","author":"Cheng","year":"2020","journal-title":"Neuroimage Clin."},{"issue":"10","key":"10.1016\/j.neuroimage.2026.121953_bib0029","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.30265","article-title":"Substantia Nigra iron deposition in lewy body disease: a magnetic resonance imaging and neuropathology study","volume":"40","author":"Diaz-Galvan","year":"2025","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.neuroimage.2026.121953_bib0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mds.26417","article-title":"Quantitative susceptibility mapping of the midbrain in Parkinson's disease","volume":"31","author":"Du","year":"2016","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neuroimage.2026.121953_bib0007","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11682-018-9842-z","article-title":"Quantitative susceptibility mapping as a biomarker for evaluating white matter alterations in Parkinson's disease","volume":"13","author":"Guan","year":"2019","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.neuroimage.2026.121953_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2024.120547","article-title":"Neuroimaging of Parkinson's disease by quantitative susceptibility mapping","volume":"289","author":"Guan","year":"2024","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.neuroimage.2026.121953_bib0022","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.21037\/qims-24-168","article-title":"Quantitative susceptibility mapping of subcortical iron deposition in Parkinson disease and multiple system atrophy: clinical correlations and diagnostic implications","volume":"14","author":"Guo","year":"2024","journal-title":"Quant. Imaging Med. Surg."},{"issue":"10","key":"10.1016\/j.neuroimage.2026.121953_bib32","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/mdc3.70153","article-title":"Magnetic susceptibility and area in the subthalamic nucleus measured by QSM for diagnosis of progressive supranuclear palsy","volume":"12","author":"Haji","year":"2025","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"4","key":"10.1016\/j.neuroimage.2026.121953_bib0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4329\/wjr.v10.i4.30","article-title":"Susceptibility weighted imaging: clinical applications and future directions","volume":"10","author":"Halefoglu","year":"2018","journal-title":"World J. Radiol."},{"key":"10.1016\/j.neuroimage.2026.121953_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.120181","article-title":"msQSM: morphology-based self-supervised deep learning for quantitative susceptibility mapping","volume":"275","author":"He","year":"2023","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.neuroimage.2026.121953_bib0016","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00234-017-1870-7","article-title":"Differential diagnosis of parkinsonism by a combined use of diffusion kurtosis imaging and quantitative susceptibility mapping","volume":"59","author":"Ito","year":"2017","journal-title":"Neuroradiology"},{"key":"10.1016\/j.neuroimage.2026.121953_bib0024","series-title":"Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects","article-title":"Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis","author":"Kouli","year":"2018"},{"issue":"9","key":"10.1016\/j.neuroimage.2026.121953_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162460","article-title":"Quantitative susceptibility mapping in Parkinson's disease","volume":"11","author":"Langkammer","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.neuroimage.2026.121953_bib0025","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1007\/s00415-013-6951-x","article-title":"Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy","volume":"260","author":"Lee","year":"2013","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.neuroimage.2026.121953_bib0027","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mds.27381","article-title":"Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes","volume":"33","author":"Lewis","year":"2018","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.neuroimage.2026.121953_bib0017","first-page":"1429","article-title":"The value of quantitative susceptibility mapping and morphometry in the differential diagnosis of parkinsonism","volume":"46","author":"Li","year":"2025","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.neuroimage.2026.121953_bib0031","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00004728-200109000-00007","article-title":"Short-echo time proton MR spectroscopy in the presence of gadolinium","volume":"25","author":"Lin","year":"2001","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.neuroimage.2026.121953_bib0018","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221143834","article-title":"Parkinson's disease or multiple system atrophy: potential separation by quantitative susceptibility mapping","volume":"16","author":"Marxreiter","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.neuroimage.2026.121953_bib33","doi-asserted-by":"crossref","first-page":"101999","DOI":"10.1016\/j.nicl.2019.101999","article-title":"Quantitative susceptibility mapping in atypical Parkinsonisms","volume":"24","author":"Mazzucchi","year":"2019","journal-title":"Neuroimage Clin"},{"issue":"10","key":"10.1016\/j.neuroimage.2026.121953_bib0019","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/ene.15447","article-title":"Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms","volume":"29","author":"Mazzucchi","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"11","key":"10.1016\/j.neuroimage.2026.121953_bib0026","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00234-019-02253-6","article-title":"Potential usefulness of signal intensity of cerebral gyri on quantitative susceptibility mapping for discriminating corticobasal degeneration from progressive supranuclear palsy and Parkinson's disease","volume":"61","author":"Miyata","year":"2019","journal-title":"Neuroradiology"},{"key":"10.1016\/j.neuroimage.2026.121953_bib0012","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neuroimage.2026.121953_bib0002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fncir.2019.00050","article-title":"Quantitative susceptibility mapping and resting State network analyses in parkinsonian phenotypes-a systematic review of the literature","volume":"13","author":"Pelzer","year":"2019","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.neuroimage.2026.121953_bib0008","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.parkreldis.2021.12.004","article-title":"Machine learning trained with quantitative susceptibility mapping to detect mild cognitive impairment in Parkinson's disease","volume":"94","author":"Shibata","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuroimage.2026.121953_bib0014","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.parkreldis.2017.08.029","article-title":"Quantitative susceptibility mapping differentiates between parkinsonian disorders","volume":"44","author":"Sjostrom","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.neuroimage.2026.121953_bib0020","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1038\/s41598-019-42565-4","article-title":"Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism","volume":"9","author":"Sjostrom","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroimage.2026.121953_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111598","article-title":"Comparative analysis of quantitative susceptibility mapping in preclinical dementia detection","volume":"178","author":"Suresh Paul","year":"2024","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.neuroimage.2026.121953_bib0013","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"3","key":"10.1016\/j.neuroimage.2026.121953_bib0028","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mds.29311","article-title":"Susceptibility magnetic resonance imaging correlates with glial density and tau in the Substantia Nigra Pars Compacta","volume":"38","author":"Wang","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroimage.2026.121953_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106549","article-title":"Quantitative susceptibility mapping of multiple system atrophy and Parkinson's disease correlates with neurotransmitter reference maps","volume":"198","author":"Yan","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroimage.2026.121953_bib0021","article-title":"Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders","volume":"14","author":"Zhang","year":"2022","journal-title":"Front. Aging Neurosci."}],"container-title":["NeuroImage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811926002685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811926002685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:02:16Z","timestamp":1793952136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053811926002685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S1053811926002685"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroimage.2026.121953","relation":{},"ISSN":["1053-8119"],"issn-type":[{"value":"1053-8119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic utility of quantitative susceptibility mapping in Parkinson's disease and atypical parkinsonism: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"NeuroImage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroimage.2026.121953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"121953"}}